Author: Craig Boerner
Jun. 24, 2020—Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19.
Sep. 19, 2019—A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
May. 17, 2018—Local comedian Ashley Corby, 35, overshares with her audience as part of her standup routine, including a 5-minute bit about “shady” rest areas she has visited due to interstitial cystitis (IC), a bladder pain syndrome affecting 3 million to 8 million people in the United States.
May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.
Mar. 8, 2018—The American Urological Association has announced three new assistant secretary positions, including Vanderbilt’s Sam Chang, MD, to better align its international growth.
Feb. 27, 2018—Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications.
Feb. 12, 2018—The Tennessee Poison Center (TPC) is celebrating its 30th anniversary this month, following a year in which it received more than 50,000 emergency calls from residents, healthcare professionals, emergency departments and intensive care units.
Nov. 16, 2017—A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.
Nov. 9, 2017—A combination of two antibiotics is often prescribed to treat community-acquired pneumonia in children, but a JAMA Pediatrics study is now showing that using just one of the two has the same benefit to patients in most cases.